About Us

Press

Another Press Release

May 31, 2021
Download PDF

Test Press Release

May 31, 2021
Download PDF

Voluptates Vel Aut

May 31, 2021
Download PDF

Magni Voluptatibus Ad Voluptatum

May 31, 2021
Download PDF

Deleniti

May 31, 2021
Download PDF

Quis Tenetur Eveniet

May 31, 2021
Download PDF

Illumacell Leadership

Michael Ben
Michael Ben, CPA, CA, CF
President

Michael has deep operational experience while holding senior positions as Controller, V.P. & General Manager, and Chief Financial Officer at various public and private corporations. He earned his Chartered Accountant degree (now CPA) at PricewaterhouseCoopers and then his international Corporate Finance (CF) designation, placing first in Canada on the final exam. While CFO, he has taken two companies public by IPO and RTO.

Jeff Hummel
Jeff Hummel, Ph.D.
VP Regulatory and Clinical Affairs

Jeff has an extensive 25 year history of working in the cancer research industry. He earned his Ph.D. in Medical Oncology from the University of Toronto and Princess Margaret Hospital. His professional expertise includes novel cancer therapies translational and clinical development regulatory affairs, clinical trial design and execution, and biomedical engineering. He has been a part time lecturer at McMaster University while being engaged with oncolytic virus research.

Tom Kerber
Tom Kerber
Founder & CTO

Tom is an entrepreneur who excels at leading creative research and development programs. As president of his electronic development company for over 30 years, Tom has developed leading technologies in multiple high power LED cooling applications and high power density designs. He was responsible for the launch of the new high powered LED based Blue Wand dental technology which revolutionized the curing of white filling materials.

Robert Zawydiwski
Robert Zawydiwski, Ph.D.
VP Science

Robert has a Ph.D. in pharmaceutical sciences and 25+ years of experience conducting basic and applied research in biology and in vitro diagnostics.  His background includes therapeutic and diagnostic oncology and medical device development.

Eric Merger
Eric Meger, MBA
Director

Eric is CEO of Maerospace Corporation which is a leader in maritime intelligence through deployment of advanced radar technologies and global satellite AIS ship tracking. Having earned a Harvard MBA and a degree in Physics from Washington University in St. Louis, Eric has worked for NASA, led international product rollouts at Glenayre and Wavetek, led Broadband Learning's successful RTO on the TSX Venture Exchange for Broadband Learning and was instrumental in COM DEV's launch of exactEarth.

Dwayne Quinn
Dwayne Quinn, P.Eng, MBA
Director

Dwayne manages a consulting business focused on energy regulatory issues. Previously he was responsible for strategy and marketing at Kitchener Utilities (natural gas). Dwayne has a P.Eng and a MBA (WLU).

Bob Tonner
Bob Tonner
Director

Bob established and runs nrgMax, an engineering firm that specializes in the design and manufacturing of embedded control and equipment protection that serves diverse markets. Bob is entrepreneurial and loves to focus on sales and marketing issues.

Advisors

Amol Karnick
Amol Karnick, MSc

Amol is an experienced medtech executive who has overseen the founding growth and successful exit of multiple medical technology companies. He has a Masters in Electrical Engineering and is currently President of KA Imaging, a Waterloo based medical imaging company.

Kate Stohlman
Kate Stohlman, MBA

Kate is an experienced medical device executive working in Boston. She has a MBA (Harvard) and currently is employed as Vice President Quality and Regulatory Affairs at Corvia Medical Inc.

Vlade Gagovski
Vlade Gagovski, M.D.

Through his Cancer Immunotherapy Centres in Toronto, Dr. Gagovski has a special interest in the comprehensive treatment of solid tumors and is highly knowledgeable of Photodynamic Therapy (PDT). This interest broadened into developing treatments that would integrate and support more commonly used traditional treatments.

Advisors

Amol Karnick

Amol is an experienced medtech executive who has overseen the founding growth and successful exit of multiple medical technology companies. He is currently President of KA Imaging, a Waterloo based medical imaging company.

Kate Stohlman

Kate is an experienced medical device executive working in Boston. She has a MBA (Harvard) and currently is employed as Vice President Quality and Regulatory Affairs at Corvia Medical Inc.

James Henry, Ph.D.

Dr. James L. Henry is a leading cellular and systems neurophysiologist with over 200 peer-reviewed papers. He spent his career at McGill and was recruited in 2002 to the University of Western Ontario as the inaugural Chair of the Department of Physiology and Pharmacology. In 2005 he was recruited to McMaster as the inaugural Scientific Director of the Michael G. DeGroote Institute for Pain Research and Care.

Vlade Gagovski, M.D.

Through his Cancer Immunotherapy Centres in Toronto, Dr. Gagovski has a special interest in the comprehensive treatment of solid tumors and is highly knowledgeable of Photodynamic Therapy (PDT). This interest broadened into developing treatments that would integrate and support more commonly used traditional treatments.

light therapy

“The Illumacell photodynamic treatment of mice with a subcutaneous malignant breast cancer resulted in a dramatic reduction in the size or outright elimination of the tumor. On histological analysis a remarkable inflammatory response coincided with the reduction or elimination of the tumor. The data from the pathological analysis indicate that the Illumacell treatment is responsible for the mounting of a remarkable and effective inflammatory response of the animal body that can result in complete elimination of the malignant tumor.”

Jacek M. Kwiecien DVM, MSc, PhD.
Assistant Professor, Department of Pathology & Molecular Medicine
Veterinary Research Pathologist & Clinical Veterinarian
McMaster University